Perrigo Co. Plc (PRGO)

45.96
0.48 1.10
NYSE
Prev Close 45.48
Open 45.70
Day Low/High 45.27 / 45.85
52 Wk Low/High 40.01 / 63.86
Volume 431.84K
Exchange NYSE
Shares Outstanding 136.48B
Market Cap 6.21B
P/E Ratio 26.38
Div & Yield N.A. (N.A)
Cramer: Papa's Got a Brand New Bag, and Leaves Perrigo Holding the Old One

Cramer: Papa's Got a Brand New Bag, and Leaves Perrigo Holding the Old One

Everything about the CEO's move to Valeant stinks.

Perrigo downgraded at Jefferies

The Trader Daily: Volatility Cuts Both Ways

The Trader Daily: Volatility Cuts Both Ways

Trying to exploit the PRGO-VRX dealings could leave you with a losing hand.

Jim Cramer Says There are a Lot of Questions Around Perrigo, Valeant

Jim Cramer Says There are a Lot of Questions Around Perrigo, Valeant

Jim Cramer says there are still a lot of questions around Valeant, which named a new CEO, Joseph Papa today.

Valeant Names Perrigo's Joseph Papa Chairman and CEO; Shares Jump

Valeant Names Perrigo's Joseph Papa Chairman and CEO; Shares Jump

Valeant delighted shareholders Monday with news that Perrigo's Joseph Papa is getting into the driver's seat. 

U.S. Stocks Open Lower, Earnings and Fed in the Spotlight

U.S. Stocks Open Lower, Earnings and Fed in the Spotlight

U.S. stocks opened lower Monday morning in a busy week for economic and earnings news.

2 Value Stocks That Are Still in Play

2 Value Stocks That Are Still in Play

Perrigo is in a CEO battle, while Bunge has undergone a quiet rise.

Valeant's Shares Could Rebound if Papa Named New CEO, Analysts Say

Valeant's Shares Could Rebound if Papa Named New CEO, Analysts Say

Wall Street is confident that Valeant can turn around its steep share price decline with the right successor as CEO.

The Valeant Saga Triggers Buying Opportunities in Biotech Stocks

The Valeant Saga Triggers Buying Opportunities in Biotech Stocks

Other companies have suffered following the debacle.

Valeant Triggers Buying Opportunities

Valeant Triggers Buying Opportunities

Other companies have suffered following the debacle.

Bearish Signals Are Rising

Bearish Signals Are Rising

The market went too far, too fast. 

You Can Be Data Dependent, Too

You Can Be Data Dependent, Too

The Fed isn't the only one that can use facts in shaping decisions.

Perrigo downgraded at Goldman

Dinged Perrigo Presents Prime Opportunity

Dinged Perrigo Presents Prime Opportunity

Its best entry points over the last nine years looked very similar to the company's current valuation.

Virtual Reality Hype Carries Nvidia to Top of S&P 500 off Earnings Beat

Excitement surrounding 3D-technology appears to be paying off for Nvidia.

Generic Drug ETF Offering Portfolio Cure

Generic Drug ETF Offering Portfolio Cure

With biotech stocks getting smashed on the stock market and big pharma getting hammered on the presidential campaign trail, generic drug stocks look awfully appealing.

Perrigo upgraded at Argus

China Drives Another Nail in the Coffins of GNC and Vitamin Shoppe

China Drives Another Nail in the Coffins of GNC and Vitamin Shoppe

Stand-alone vitamin and supplement shops like GNC and Vitamin Shoppe shares will continue to fall in light of a Justice Department investigation.

2 Safe and Cheap Health Care Stocks

2 Safe and Cheap Health Care Stocks

These two will continue to churn out earnings growth.

Bear Chart of the Day: Perrigo

Bear Chart of the Day: Perrigo

Buying it here would be like trying to catch a falling knife.

Mylan Plans Hostile Takeover of Perrigo; Stocks Rebound in Rally

Mylan Plans Hostile Takeover of Perrigo; Stocks Rebound in Rally

Mylan (MYL) gained ground Tuesday after it announced plans to start a $27.1 billion hostile takeover of Perrigo (PRGO).

U.S. Stocks Open Lower as Personal Income and Spending Climb

U.S. Stocks Open Lower as Personal Income and Spending Climb

U.S. stocks opened lower Friday as personal income and spending both rose in July.

Rising Rates Won’t Slow Deal Flow Says Kellner Fund Manager

Rising Rates Won’t Slow Deal Flow Says Kellner Fund Manager

Deal flow has been massive in the first half of 2015 from healthcare to technology to insurance.

Strong Economy Will Push Israeli Stocks Higher Says Aberdeen Fund Manager

Strong Economy Will Push Israeli Stocks Higher Says Aberdeen Fund Manager

The Israeli economy is strong, growing fast and offers good value, according to William Scholes, investment manager for Aberdeen Asset management.

Health Care Mergers Are Just Getting Started

Deals coming fast and furious in the best group in town.

Deluge of Deals Isn't About to Dry Up

Acquisitions cut into overabundance of companies.

Rising Interest Rate Environment Won't Derail Merger Fund

Rising Interest Rate Environment Won't Derail Merger Fund

The Merger Fund seeks absolute returns and is not correlated to the stock market so it will fare well in a rising rate environment.

Dealmaking Frenzy Leads to Heady Days for Event-Driven Funds

Dealmaking Frenzy Leads to Heady Days for Event-Driven Funds

The surge in deal-making has created the ideal environment for merger arbitrage or event-driven funds, said K.C. Nelson, portfolio manager for the Driehaus Event Driven Fund.

Amazon Leads Stock Markets; Nasdaq Extends Record Run

Amazon Leads Stock Markets; Nasdaq Extends Record Run

The Nasdaq was the clear winner on markets Friday. The tech-heavy index spiked into record territory as Amazon (AMZN), Microsoft (MSFT) and Google (GOOGL) rallied after reporting earnings.

Japanese Stocks Hit 15-Year High

And four other things you need to know now.